Covishield showed small risk of very rare blood clotting disorder after 1st dose: Details
The AstraZeneca COVID-19 vaccine is associated with a small risk of rare blood clots after the first dose, and no extra risk after the second shot, according to a study led and funded by the British-Swedish drugmaker.
The research,!-->!-->!-->…
Read More...
Read More...